Forgot your password?


To create an account to access your personal
My Account OR Dashboard, click REGISTER below.


New Provider Enrollment

To access on-line enrollment / new provider package, click ENROLL below.


Generating Discoveries That Lead To New Treatments Is Top Goal Of New Associate Director For Research At SBUCC


Dr. Michael J. Hayman, Biochemist
and Long-Time Cancer Researcher

Michael J. Hayman, Ph.D., has been named Associate Director for Research of the Stony Brook University Cancer Center. Appointed by Richard N. Fine., M.D., Dean of the School of Medicine, Dr. Hayman has been a cancer researcher for 30 years and has served as a Professor of Molecular Genetics & Microbiology for the past 22 years.

Dr. Hayman will spearhead the collaboration of investigators involved in cancer-related research across many clinical and basic science departments at Stony Brook, such as Molecular Genetics & Microbiology, Pharmacological Sciences, Biochemistry & Cell Biology, Chemistry, Surgery, Urology and Pediatrics.

"A significant mission of the Stony Brook University Cancer Center is to foster research activities in all areas related to cancer, and Dr. Hayman is well suited to assume this task," says Dr. Fine, who notes that with the opening of the Cancer Center outpatient facility, the Medical Center is poised to assume a leadership role in providing care for Long Islanders with cancer.

"Research and patient care go hand-in-hand," says Martin S. Karpeh, Jr., Director of the Cancer Center. "In order to provide the best treatments, cutting edge research involving both basic and clinical investigators must be a growing part of the Cancer Center. Dr. Haymanís background, expertise, and vision will help bring our most promising research to the forefront to impact patient care."

"My goal is to provide an environment where basic and translational research can flourish to generate new discoveries that will provide the framework for future new treatments," says Dr. Hayman, whose laboratory research centers on understanding the mechanisms that control proliferation, differentiation, and death of cells, and how oncoproteins subvert these mechanisms to cause cancer.

Dr. Hayman says that the Cancer Center will look to develop targeted therapies resulting from basic research that successfully translates to the clinic. Such discoveries, he points out, may come about through collaborative investigations between different disciplines, such as molecular biology, cancer biology, immunology or genetics, and through many approaches. As an example, one approach is research of inhibitors of specific enzymes that are activated in certain cancers. GleevecTM, a drug widely used to treat chronic mylogenous leukemia (CML) in recent years, is an example of a successful treatment based on this approach.

Dr. Hayman, a member of the American Society of Microbiology, the British Society of Cell Biology, and the American Association for Cancer Research, received his doctorate in Biochemistry from the National Institute for Medical Research in London. Dr. Hayman lives in East Patchogue with his wife, Paula Enrietto, and son, Matthew.

Make An Appointment

Important Note:

The Stony Brook Medicine University Physicians website is primarily an informational and educational resource. It should not be used in place of medical advice and recommendations you receive from your health care provider. If you have, or suspect that you have a medical problem or condition, please seek the advice of your health care provider.

Stony Brook Medicine University Physicians provides marketing advice and consultation to the clinical Faculty associated with the University Faculty Practice Corporations (UFPCs). It does not provide medical care directly or indirectly nor does it oversee, direct, manage or supervise the medical care provided by any of the individual Practices. The individual Practices are responsible for the medical care each Practice provides to its patients. Please note that the Practices listed below are separate University Faculty Practice Corporations (UFPCs).